Collegium Pharmaceutical, Inc. (COLL)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 02:35PM EDT. Market open.
| Previous close | 37.51 |
| Open | 37.51 |
| Bid | 37.14 x 100 |
| Ask | 37.32 x 100 |
| Day's range | 37.15 - 37.92 |
| 52-week range | 20.83 - 40.95 |
| Volume | |
| Avg. volume | 429,230 |
| Market cap | 1.218B |
| Beta (5Y monthly) | 1.04 |
| PE ratio (TTM) | 28.87 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Collegium Pharmaceutical (COLL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Collegium (COLL) to Report Q1 Earnings: Here's What to Expect
Collegium's (COLL) top line is likely to have been fueled by growth in the sales of pain drugs, Belbuca and Xtampza ER, in the first quarter of 2024.
- Simply Wall St.
Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) ROE Of 25% Impressive?
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
© 2024 Yahoo. All rights reserved.